Celestial Labs Limited IPO Message Board (Page 5)

please do not invest in this issye as it is a fixed price issue...

can any one tell me the allotment/listing dates...of roman tarmat limited ,dlf limited ,vishal retail limited ,meghmani organics limited , icici bank limited ....i had applied for minimum quantity....what are the chances of allotment ? from which website allotments can be known?
samir

Please advise us how good is it to invest in celestial IPO.

INTERVIEW OF ADITYA NARAYAN SINGH, CHAIRMAN CUM MANAGING DIRECTOR, CELESTIAL LABS LTD.



What are your major strengths?

Our strengths are large local market, good export market, strong base for contract research for international companies due to rising R & D costs abroad and Large number of patients covering a wider range of diseases

What has been the major reason of revenue growth recently and what is your strategy to enhance the revenue stream?

The biotechnology sector is witnessing an impressive annual growth realized through incremental revenues and the addition of new companies. Much of our recent revenue growth is the result of growth in the bio-information segment & data warehousing segment. As an upward integration strategy enhancing the regular revenue stream, CELESTIAL is leveraging its expertise in Fermentation process, has signed a technology transfer agreement with Institute of Microbial Technology (IMTECH), a premier CSIR organization at Chandigarh, India, to manufacture two industrially important enzymes, alpha Amylase and alkaline Protease and market them in India and overseas.

What are your plans to set up office abroad?

We intend to set up an overseas office in the United States to tap the US market, which offers a huge potential.

What is the status of IPRs?

We have applied to Patents Office, Chennai, relating to “Anti cancer peptide drugs with novel activity and their biotechnological production“ and “Novel human basic fibroblast factor active site, mutated at one or more positions to increase the efficacy of vitiligo treatment”. The Company has also applied for registration of Copyright of five titles ‘Ratna’, ‘Vyasa’, ‘Sahakar’, ‘CELSUITE’ and Dhanvantari.

What is your focus?

The focus is to use multi disciplinary skills to visualize and tackle problems in right perspective. This has enabled CELESTIAL to attract and retain highly qualified personnel having a wide knowledge base in different areas such as microbiology, biochemistry, toxicology etc. Besides the technical, programme implementation and effective management skills, these personnel are equipped with expertise in research, economic affairs and entrepreneurship background.

What are your credentials as a promoter?

I am B.Tech from Pant University of Agriculture & Technology, Nainital in Agricultural Engineering with a post graduate Diploma in Business Management (MBA) from Xavier Institute of Management, Bhubaneswar . I worked at ICRISAT Hyderabad for about 15 years and have working experience of bioinformatics extensively. I was also involved in providing the technology transfer at Nigeria in the field of Bio Processing. I have experience in Intellectual property rights matter and knowledge in IPR Database search. I am in Biotechnology field for about two decades.

What are your company’s technological strengths?

We have developed a de novo drug design tool “CELSUITE” to aid the pharma industry in discovering new molecules for curing different diseases. This tool will enable the company not only to design new molecules for its own purpose but also to provide the bio-informatics services to the various pharma and biotech companies.

Based on the company’s in silico expertise (applying bioinformatics tools), the company has developed therapeutic molecules to treat Leucoderma and multiple cancers. The cloned molecules are being subjected for purification by the wet lab procedures at the company’s collaborative Institute, Department of Microbiology, Osmania University , Hyderabad .

In the industrial biotechnology area, the company has signed the technology transfer agreement with IMTECH Chandigarh (a very reputed Council of Scientific & Industrial Research organization) for the manufacture of two industrial enzymes – alpha Amylase and alkaline Protease. Initially these would be marketed in India and later overseas.

The company has initiated setting up of a biotechnology facility to develop its drug molecules and manufacture industrial enzymes. This facility would also include the research laboratories for carrying out further R & D activities to develop new related products for reducing wrinkles / stretch marks and acceleration of wound healing from the same chemical structure of vitiligo.We have also plans to cater to the laboratory process outsourcing by using innovative platform technologies/services in the field of analytical laboratory and bio-computational systems. The company is positioned to drive innovations and support activities in post genome advancements via clinical trials (CT) and laboratory process outsourcing (LPO) to be a significant player in personalized medicine in select disease areas.

Initial reports abt this issue are positive to certain extent.. Lets wait and watch

celestial IPO is a good opportunity for small investors.

NOT A GOOD ISSUE.
FIXED PRICE ISSUE YOU WILL NEVER NO SUBSCRIPTION FIGURES UNTILL CLOSING OF THE ISSUE.
THINK BEFORE APPLYING.

ipo is not good

the ipo is good.to the mymind fii should intrest in this ipo

Hi all,
Don't touch these fixed price issue.You will not be knowing the number of times it is getting subscribed.You will end up getting full allotment and you will cry.Remember Hilton??IPO rating is 1 which is below investment grade.No FII or other big investor will put in their apps.Why do you want get stuck.If you are so keen on this company get it from the market after listing at a lower price ie at a discount to offer price.
All the best Celestial.Hope you sail through!!!And not crash from Celestica

Dear Borders as i advised you to apply for vishal retail it has subscribed 50 times in retail section if you get allotment it is a lottery.this issue is expensive in peer group avoid it.Regards

This IPO doesn"t seem to be good. Wait & watch.I will give my final recomendation on 15 June 2007

is it a good issue?

i think it may be good issue

are bhai ajay tum ne to nitin me kama liya aab kya gabhra rahe ho tum vishal roman aur celestial bhardo kyoki yah sub choti equity wale ipo hai yah tino bharo aur moj karo good investing..............

Dear Ajay,you can apply vishal retail as it is cheaper in its peer group pantaloon .provogue,and many more retail chains. it is a Bengal based company and owened by Rajasthani.the co has given presence in jaipur and jodhpur.they have taen over the sales of national handloom a retail chain of rajasyhan and gujrat.it is cheap and grey market premium is high . no risk apply.

kya hai bhai issue me kuchh dam hai ke nahi.
ek company ka ipo pura hua aur dusari company ka ipo aa gaya mujhe to aisa lagta hai ki sub retail investors ko fasa to nahi denge na ?
hum ne abhi tak 3 ipo bhare hai time nitin aur meghmani ab konsa ipo select kare please chartis batana.

Investors who are applying for 1 lac will get the appreation of 3000-6000 rs on listing............ best of luck for all lucky investors